Design and fermented production of recombinant peptide for reducing blood pressure
A technology for antihypertensive peptides and expression vectors, applied in fermentation, recombinant DNA technology, peptides, etc., can solve problems such as high production costs and difficult implementation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] 1. Gene design and synthesis: According to animal experiments or human food effects, small peptides that do have antihypertensive effects and are derived from human food are collected to form a small peptide library (specify peptide library). Select one or more of them to form a fusion protein, and convert the amino acid sequence of the fusion protein into the nucleotide sequence of the coding gene according to the Escherichia coli preference code. The gene was fully synthesized by chemical synthesis.
[0016] GAATCCCGCGGCCACAAAATCGCGACCTTTCAGGAACGCCTGTATCCGG
[0017] TGCGCGCGGTGAACCCGATTCGCGCGGTGCCGTATCCGCAGCGCCTGC
[0018] GCCCGTAAAAGCTT
[0019] 2. Construction of expression vector and acquisition of engineering bacteria: select the commercialized plasmid pET-28a (+) of Novagen Company as the carrier, carry out double enzyme digestion (Eco R I+Hind III) of the target gene and the carrier DNA, and use T 1 DNA ligase is used for ligation, and the product of the liga...
Embodiment 2
[0026] The small peptide produced by fermentation of the present invention is used in the antihypertensive test, and the result is the same as the antihypertensive peptide obtained from natural sources.
[0027] The test method for antihypertensive peptides to inhibit ACE I activity is quoted from: "Functional Fermented Products" edited by You Xin, p: 220-221, China Light Industry Press, 2000.1, first edition.
[0028] Table 1. The effect of antihypertensive peptides prepared from food on inhibiting ACE I
[0029] Preface
[0030] Table 2. Recombinant antihypertensive peptides inhibit ACE I effect in the present invention
[0031] Preface
[0032] Note: IC 50 (μmol / L) refers to the concentration of antihypertensive peptide required when ACE I activity is inhibited to half. The smaller the value, the stronger the pressure reducing effect.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 